Aaruni Saxena

420 total citations
10 papers, 291 citations indexed

About

Aaruni Saxena is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Aaruni Saxena has authored 10 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Aaruni Saxena's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Computational Drug Discovery Methods (3 papers) and Click Chemistry and Applications (2 papers). Aaruni Saxena is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Computational Drug Discovery Methods (3 papers) and Click Chemistry and Applications (2 papers). Aaruni Saxena collaborates with scholars based in India, Germany and United Kingdom. Aaruni Saxena's co-authors include Thomas Hohlfeld, Anil K. Saxena, Karsten Schrör, Vishal M. Balaramnavar, Asmita Samadder, Sisir Nandi, Andrea Icks, Karsten Müssig, Michael Roden and Bettina Nowotny and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Aaruni Saxena

9 papers receiving 280 citations

Peers

Countries citing papers authored by Aaruni Saxena

Since Specialization

Citations

This map shows the geographic impact of Aaruni Saxena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaruni Saxena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaruni Saxena more than expected).

Fields of papers citing papers by Aaruni Saxena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaruni Saxena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaruni Saxena. The network helps show where Aaruni Saxena may publish in the future.

Co-authorship network of co-authors of Aaruni Saxena

This figure shows the co-authorship network connecting the top 25 collaborators of Aaruni Saxena. A scholar is included among the top collaborators of Aaruni Saxena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaruni Saxena. Aaruni Saxena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Small Molecules as Immune Checkpoint Inhibitors in Cancer Therapeutics 2024 ·(unknown), Aaruni Saxena, Anil K. Saxena	2
2	[Final accepted version, unedited] Exploring the inhibitory mechanisms of indazole compounds against SAH/MTAN-mediated quorum sensing utilizing QSAR and docking 2022 ·SHILAP Revista de lepidopterología ·Sisir Nandi, Mohit Kumar, (unknown), Aaruni Saxena	3
3	Current Naturopathy to Combat Alzheimer’s Disease 2022 ·Current Neuropharmacology ·(unknown), (unknown), Aaruni Saxena, Asmita Samadder, Sisir Nandi	10
4	Natural Sourced Inhibitors of EGFR, PDGFR, FGFR and VEGFRMediatedSignaling Pathways as Potential Anticancer Agents 2021 ·Current Medicinal Chemistry ·Sisir Nandi, (unknown), Asmita Samadder, Aaruni Saxena, Anil K. Saxena, (unknown), (unknown)	21
5	Exploring the Potential Inhibition of Candidate Drug Molecules for Clinical Investigation Based on their Docking or Crystallographic Analyses against M. tuberculosis Enzyme Targets 2020 ·Current Topics in Medicinal Chemistry ·(unknown), Sisir Nandi, Asmita Samadder, Aaruni Saxena, Anil K. Saxena	23
6	Cohort profile: the German Diabetes Study (GDS) 2016 ·Cardiovascular Diabetology ·(unknown), Julia Szendroedi, Aaruni Saxena, Katharina S. Weber, Klaus Straßburger, Christian Herder, Volker Burkart, Bettina Nowotny, Andrea Icks, Oliver Kuß, Dan Ziegler, Hadi Al‐Hasani, Karsten Müssig, Michael Roden	97
7	Novel Glycoprotein VI Antagonists as Antithrombotics: Synthesis, Biological Evaluation, and Molecular Modeling Studies on 2,3-Disubstituted Tetrahydropyrido(3,4-b)indoles 2016 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Imran A. Khan, (unknown), Manish Jain, Surendra P. Singh, Aaruni Saxena, (unknown), Madhu Dikshit, Anil K. Saxena	20
8	Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets 2013 ·European Journal of Pharmacology ·Aaruni Saxena, Vishal M. Balaramnavar, Thomas Hohlfeld, Anil K. Saxena	65
9	High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs – pharmacological mechanisms and clinical relevance 2012 ·Thrombosis and Haemostasis ·Aaruni Saxena, Karsten Schrör, Thomas Hohlfeld	50
10	Quantitative pharmacokinetic patients relationship (QPPR) for piperacillin−tazobactam during continuous venovenous heamodialysis/filtration 2008 ·Medicinal Chemistry Research ·Aaruni Saxena, (unknown), (unknown), Bernd Drewelow	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact